Quantum Genesis AI Corp.

Quantumzyme is a pre-revenue micro-cap shell with an explicit going-concern doubt and essentially no liquidity.

Strengths

• Has engineered an initial enzyme product for ibuprofen API
• Operating expenses are small and contained (~$181K/yr)

Risks

• Going concern: $5.6M accumulated deficit, $441K current liabilities vs $584 current assets (current ratio 0.001)
• No revenue, no patent protection, and total dependence on dilutive outside financing to survive

Notable findings

• No interest coverageInterest coverage -8.50 (cannot cover interest)
• Going concernThese conditions raise substantial doubt about the Company's ability to continue as a going concern
• Weak liquidityCurrent ratio 0.00 (<1)